For the quarter ended December 31, 2025, Apogee reported a net loss of 255843000 and an operating loss of 285595000, driven by research and development expenses of 214712000 and general and administrative expenses of 70883000. The company ended the year with 131549000 in cash and cash equivalents.
Net loss for Q4 2025 was 255843000.
Operating loss totaled 285595000 for the quarter.
Research and development expenses were 214712000.
Cash and cash equivalents were 131549000 at December 31, 2025.
The company expects its existing cash, cash equivalents and marketable securities to fund operations for at least the next 12 months.
Analyze how earnings announcements historically affect stock price performance